Literature DB >> 15009107

A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.

A M G Pasmooij1, S van Zalen, A M Nijenhuis, A J Kloosterhuis, J Zuiderveen, M F Jonkman, H H Pas.   

Abstract

Mutations in the gene COL17A1 cause non-Herlitz junctional epidermolysis bullosa. Here, we describe a patient who, despite two heterozygous mutations in COL17A1, has an extremely mild form of the disease missing most of the characteristic clinical features. DNA analysis revealed a frame-shift mutation 3432delT and a nonsense mutation 2356C-->T (Q751X). cDNA analysis showed that the deleterious effect of the latter mutation was skirted by deleting the premature termination codon containing exon 30. In this way, the reading frame was restored, resulting in a 36 nucleotides shorter mRNA transcript. Immunoblot analysis showed expression of the 180-kDa bullous pemphigoid antigen (BP180) with a slightly higher SDS-PAGE mobility, in line with the deletion of 12 amino acids from the COL15 domain. Immunofluorescence of skin sections showed diminished, but correctly localised expression of BP180, and this, in concert with the mild clinical phenotype, suggests that this COL15 mutated BP180 is still partly functional.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009107     DOI: 10.1111/j.0906-6705.2004.00141.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  5 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

2.  Evidence in disease and non-disease contexts that nonsense mutations cause altered splicing via motif disruption.

Authors:  Liam Abrahams; Rosina Savisaar; Christine Mordstein; Bethan Young; Grzegorz Kudla; Laurence D Hurst
Journal:  Nucleic Acids Res       Date:  2021-09-27       Impact factor: 16.971

3.  Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.

Authors:  Anna M G Pasmooij; Hendri H Pas; Maria C Bolling; Marcel F Jonkman
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

4.  Spontaneous rescue from cystic fibrosis in a mouse model.

Authors:  Nikoletta Charizopoulou; Martina Wilke; Martina Dorsch; Alice Bot; Huub Jorna; Silke Jansen; Frauke Stanke; Hans J Hedrich; Hugo R de Jonge; Burkhard Tümmler
Journal:  BMC Genet       Date:  2006-03-29       Impact factor: 2.797

5.  Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.

Authors:  Michael Ablinger; Thomas Lettner; Nicole Friedl; Hannah Potocki; Theresa Palmetzhofer; Ulrich Koller; Julia Illmer; Bernadette Liemberger; Stefan Hainzl; Alfred Klausegger; Manuela Reisenberger; Jo Lambert; Mireille Van Gele; Eline Desmet; Els Van Maelsaeke; Monika Wimmer; Roland Zauner; Johann W Bauer; Verena Wally
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.